Literature DB >> 31533599

Variances in the Level of COX-2 and iNOS in Different Grades of Endometrial Cancer.

Marcin Oplawski1,2, Konrad Dziobek3, Nikola Zmarzły2,4, Beniamin O Grabarek2,3,4, Robert Kiełbasiński5, Przemysław Kieszkowski6, Piotr Januszyk2, Karol Talkowski7, Michał Schweizer3, Piotr Kras1, Andrzej Plewka8, Dariusz Boroń1,2,8.   

Abstract

BACKGROUND: Many experimental studies have demonstrated the importance of COX-2 in the tumor angiogenesis. Inducible iNOS is responsible for a high and stable level of nitric oxide and is expressed in response to pro-inflammatory factors.
OBJECTIVE: The aim of this study was to evaluate the expression of COX-2 and iNOS at the protein level and to assess their potential prognostic significance in patients with endometrial cancer.
METHODS: The study group consisted of 45 women with endometrial cancer divided according to the degree of histological differentiation i.e. G1, 17; G2, 15; G3, 13. The control group consisted of 15 women without neoplastic changes. The expression of studied proteins was determined immunohistochemically with specific polyclonal antibodies.
RESULTS: Analysis of the COX-2 expression showed that the optical density of the reaction product in G1 reached 186% in the control group, while the values in G2 and G3 reached 243% and 293%, respectively. In the case of iNOS, the optical density of the reaction product reached the following percentages in the control group: 147% in G1, 243% in G2, and 241% in G3.
CONCLUSION: Our findings suggest that changes in the expression of COX-2 and iNOS may be potentially useful in predicting the progression of endometrial cancer and treatment effectiveness. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  COX-2; Endometrial cancer; angiogenesis; iNOS; molecular marker; neoplastic changes.

Mesh:

Substances:

Year:  2020        PMID: 31533599     DOI: 10.2174/1389201020666190918104105

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  4 in total

1.  Exosomal-lncRNA DLEU1 Accelerates the Proliferation, Migration, and Invasion of Endometrial Carcinoma Cells by Regulating microRNA-E2F3.

Authors:  Jianjun Jia; Suiqun Guo; Dong Zhang; Xiaohui Tian; Xingmei Xie
Journal:  Onco Targets Ther       Date:  2020-08-25       Impact factor: 4.147

2.  The Methyl Ester of 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid Reduces Endometrial Lesions Development by Modulating the NFkB and Nrf2 Pathways.

Authors:  Rosalba Siracusa; Ramona D'Amico; Marika Cordaro; Alessio Filippo Peritore; Tiziana Genovese; Enrico Gugliandolo; Rosalia Crupi; Daniela Impellizzeri; Salvatore Cuzzocrea; Roberta Fusco; Rosanna Di Paola
Journal:  Int J Mol Sci       Date:  2021-04-13       Impact factor: 5.923

3.  Proteomic Analysis of Endometrial Cancer Tissues from Patients with Type 2 Diabetes Mellitus.

Authors:  Muhammad Mujammami; Mohamed Rafiullah; Assim A Alfadda; Khalid Akkour; Ibrahim O Alanazi; Afshan Masood; Mohthash Musambil; Hani Alhalal; Maria Arafah; Anas M Abdel Rahman; Hicham Benabdelkamel
Journal:  Life (Basel)       Date:  2022-03-28

4.  Assessment of Expression of Homeobox A5 in Endometrial Cancer on the mRNA and Protein Level.

Authors:  Konrad Dziobek; Marcin Oplawski; Nikola Zmarzły; Beniamin O Gabarek; Robert Kiełbasiński; Kamil Kiełbasiński; Przemysław Kieszkowski; Karol Talkowski; Dariusz Boroń
Journal:  Curr Pharm Biotechnol       Date:  2020       Impact factor: 2.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.